MOS
BSX icon

MGO One Seven’s Boston Scientific BSX Stock Holding History

MGO One Seven’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$589K Buy
13,801
+2,052
+17% +$111K 0.01% 900
2026
Q1 		$737K Sell
11,749
-3,236
-22% -$259K 0.01% 771
2025
Q4 		$1.43M Sell
14,985
-5,321
-26% -$522K 0.03% 536
2025
Q3 		$1.98M Buy
20,306
+3,678
+22% +$381K 0.05% 407
2025
Q2 		$1.79M Sell
16,628
-2,774
-14% -$281K 0.06% 364
2025
Q1 		$1.96M Buy
19,402
+892
+5% +$89.8K 0.08% 285
2024
Q4 		$1.65M Sell
18,510
-568
-3% -$50K 0.06% 313
2024
Q3 		$1.6M Buy
19,078
+2,406
+14% +$190K 0.07% 287
2024
Q2 		$1.28M Buy
16,672
+8,399
+102% +$615K 0.06% 321
2024
Q1 		$567K Sell
8,273
-638
-7% -$41K 0.03% 484
2023
Q4 		$515K Buy
8,911
+411
+5% +$21.9K 0.03% 514
2023
Q3 		$449K Sell
8,500
-357
-4% -$18.7K 0.03% 478
2023
Q2 		$479K Buy
8,857
+45
+0.5% +$2.35K 0.04% 426
2023
Q1 		$441K Buy
8,812
+3,105
+54% +$146K 0.03% 520
2022
Q4 		$264K Buy
5,707
+89
+2% +$3.85K 0.03% 593
2022
Q3 		$217 Buy
5,618
+54
+1% +$2.17K 0.01% 629
2022
Q2 		$207K Sell
5,564
-4,217
-43% -$172K 0.03% 568
2022
Q1 		$433K Buy
9,781
+51
+0.5% +$2.21K 0.05% 405
2021
Q4 		$413K Buy
9,730
+2,423
+33% +$102K 0.04% 415
2021
Q3 		$315K Buy
7,307
+83
+1% +$3.67K 0.04% 439
2021
Q2 		$309K Buy
7,224
+1,489
+26% +$62.6K 0.04% 441
2021
Q1 		$221K Buy
+5,735
New +$217K 0.04% 484
2020
Q4 		– Sell
-6,210
Closed -$237K – 499
2020
Q3 		$237K Sell
6,210
-1,346
-18% -$51.9K 0.06% 384
2020
Q2 		$265K Buy
+7,556
New +$272K 0.07% 351
2019
Q1 		– Sell
-791
Closed -$27K – 569
2018
Q4 		$27K Buy
+791
New +$28.7K 0.01% 808
2018
Q1 		$21K Hold
759
– – 0.01% 848
2017
Q4 		$19K Buy
+759
New +$20.9K 0.01% 876

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MGO One Seven's BSX Position: Q2 2026 in Review

MGO One Seven increased its Boston Scientific (BSX) stake by 17% in Q2 2026, buying an estimated $111K and bringing the position to 13,801 shares worth $589K. The position accounts for 0.01% of the portfolio, ranked #900.

MGO One Seven first reported a position in BSX in Q4 2017 and has held it in 27 quarters since. The position peaked at $1.98M in Q3 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • MGO One Seven held 13,801 shares of Boston Scientific worth $589K as of Q2 2026.
  • MGO One Seven bought 2,052 Boston Scientific shares in Q2 2026, an estimated $111K.
  • Boston Scientific made up 0.01% of MGO One Seven's portfolio in Q2 2026, its #900 holding.
  • MGO One Seven first reported a position in Boston Scientific in Q4 2017 and has held it in 27 quarters since.
  • MGO One Seven's Boston Scientific position peaked at $1.98M in Q3 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.